MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)

Clinical trial NCT06437639 · COMPLETED

Trial details

NCT number: NCT06437639
Sponsor: Pharmasoft
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)

Start date: 2023-09-15
Primary completion: 2023-11-29
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.